← Back to Search

Photobiomodulation

Valeda PBM treatment for Age-Related Macular Degeneration

N/A
Waitlist Available
Research Sponsored by LumiThera, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 21 months
Awards & highlights

Study Summary

This trial is testing whether a certain eye treatment can help people with a certain type of vision problem.

Eligible Conditions
  • Age-Related Macular Degeneration

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~21 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 21 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Best Corrected Visual Acuity
Secondary outcome measures
Central Drusen Thickness
Central Drusen Volume
Other outcome measures
Contrast Sensitivity
Geographic Atrophy
Low Luminance- Best Corrected Visual Acuity
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: PBM TreatmentExperimental Treatment1 Intervention
The Valeda™ Light Delivery System
Group II: Sham TreatmentPlacebo Group1 Intervention
The Valeda™ Light Delivery System non-effective treatment
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Valeda PBM treatment
2019
N/A
~50

Find a Location

Who is running the clinical trial?

LumiThera, Inc.Lead Sponsor
4 Previous Clinical Trials
164 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)
2019. "Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04065490.
All > Age Related Macular Degeneration > Macular Degeneration
~17 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top